Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial

BACKGROUND: Circulating tumor cells (CTCs) are prognostic in patients with advanced breast cancer (ABC). However, no data exist about their use in patients treated with palbociclib. We analyzed the prognostic role of CTC counts in patients enrolled in the cTREnd study, a pre-planned translational su...

詳細記述

保存先:
書誌詳細
出版年:Breast Cancer Res
主要な著者: Galardi, Francesca, De Luca, Francesca, Biagioni, Chiara, Migliaccio, Ilenia, Curigliano, Giuseppe, Minisini, Alessandro M., Bonechi, Martina, Moretti, Erica, Risi, Emanuela, McCartney, Amelia, Benelli, Matteo, Romagnoli, Dario, Cappadona, Silvia, Gabellini, Stefano, Guarducci, Cristina, Conti, Valerio, Biganzoli, Laura, Di Leo, Angelo, Malorni, Luca
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2021
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7992319/
https://ncbi.nlm.nih.gov/pubmed/33761970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-021-01415-w
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料